{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:15:10Z","timestamp":1791008110513,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.pnpbp.2011.01.017","type":"journal-article","created":{"date-parts":[[2011,2,2]],"date-time":"2011-02-02T09:45:40Z","timestamp":1296639940000},"page":"974-981","source":"Crossref","is-referenced-by-count":30,"title":["Targeting oxidative stress, mitochondrial dysfunction and neuroinflammatory signaling by selective cyclooxygenase (COX)-2 inhibitors mitigates MPTP-induced neurotoxicity in mice"],"prefix":"10.1016","volume":"35","author":[{"given":"Amit","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.K.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2011.01.017_bb0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/WNR.0b013e3282fb7898","article-title":"The novel cyclooxygenase-2 inhibitor GW637185x protects against l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity","volume":"19","author":"Aguirre","year":"2008","journal-title":"NeuroReport"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0010","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/mds.21552","article-title":"Neuroinflammation in the pathophysiology of Parkinson's disease: evidence from animal models to human in vivo studies with [11C]-PK11195 PET","volume":"22","author":"Bartels","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0015","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1046\/j.1471-4159.1999.0731127.x","article-title":"Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease","volume":"73","author":"Berman","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0223-5234(01)01197-7","article-title":"Cyclooxygenase inhibitors \u2014 current status and future prospects","volume":"36","author":"Dannhardt","year":"2001","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0025","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0030","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0021-9258(18)57021-6","article-title":"Determination of serum proteins by means of the biuret reaction","volume":"177","author":"Gornall","year":"1949","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pbb.2009.07.018","article-title":"Protective effect of cyclooxygenase (COX)-inhibitors against drug-induced catatonia and MPTP-induced striatal lesions in rats","volume":"94","author":"Gupta","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0040","first-page":"577","article-title":"Effect of preferential cyclooxygenase-2 (COX-2) inhibitor against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced striatal lesions in rats: Behavioral, biochemical and histological evidences","volume":"48","author":"Gupta","year":"2010","journal-title":"Indian J Exp Biol"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10787-010-0052-6","article-title":"Licofelone attenuates MPTP-induced neuronal toxicity: behavioral, biochemical and cellular evidences","volume":"18","author":"Gupta","year":"2010","journal-title":"Inflammopharmacol"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0050","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1471-4159.1992.tb10990.x","article-title":"Reactive oxygen species and the central nervous system","volume":"59","author":"Halliwell","year":"1992","journal-title":"J Neurochem"},{"issue":"Supplement 2","key":"10.1016\/j.pnpbp.2011.01.017_bb0055","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1007\/BF01778304","article-title":"A structural feature of N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulfonamide (NS-398) that governs its selectivity and affinity for cyclooxygenase 2 (COX2)","volume":"44","author":"Huff","year":"1995","journal-title":"Inflamm Res"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0060","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0076-6879(67)10055-4","article-title":"Preparations and properties of soluble NADH dehydrogenases from cardiac muscle","volume":"10","author":"King","year":"1967","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0065","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1358\/dot.2009.45.2.1322481","article-title":"Cyclooxygenase in epilepsy: from perception to application","volume":"45","author":"Kulkarni","year":"2009","journal-title":"Drugs Today"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12264-010-0713-x","article-title":"Protective effects of selective and non-selective cyclooxygenase inhibitors in an animal model of chronic stress","volume":"26","author":"Kumar","year":"2010","journal-title":"Neurosci Bull"},{"issue":"3","key":"10.1016\/j.pnpbp.2011.01.017_bb0075","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1472-8206.2007.00485.x","article-title":"Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms","volume":"21","author":"Kumar","year":"2007","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0080","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/sj.bjp.0706732","article-title":"Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor","volume":"148","author":"Liu","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0085","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jnen\/63.9.901","article-title":"Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases","volume":"63","author":"Minghetti","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0090","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3727\/096368908784423328","article-title":"Neuroinflammation and peripheral immune infiltration in Parkinson's disease: an autoimmune hypothesis","volume":"17","author":"Monahan","year":"2008","journal-title":"Cell Transplant"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Meth"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0100","doi-asserted-by":"crossref","first-page":"37223","DOI":"10.1074\/jbc.M305694200","article-title":"Oxidative damage to mitochondrial complex I due to peroxynitrite","volume":"278","author":"Murray","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0105","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/00004647-199911000-00005","article-title":"The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene","volume":"19","author":"Nagayama","year":"1999","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0110","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1523\/JNEUROSCI.17-08-02746.1997","article-title":"Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage","volume":"17","author":"Nogawa","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0115","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/1-4020-5688-5_1","article-title":"Anti-inflammatory drugs in the 21st century","volume":"42","author":"Rainsford","year":"2007","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0125","doi-asserted-by":"crossref","first-page":"81s","DOI":"10.18433\/J3T886","article-title":"Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond","volume":"11","author":"Rao","year":"2008","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2006.12.032","article-title":"The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats","volume":"560","author":"Reksidler","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","article-title":"The MPTP model of Parkinson's disease","volume":"134","author":"Smeyne","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0140","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ana.410400417","article-title":"Origin and functional consequences of the complex I defect in Parkinson's disease","volume":"40","author":"Swerdlow","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U","article-title":"Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease","volume":"39","author":"Teismann","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0150","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-4159.1993.tb13610.x","article-title":"Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds","volume":"61","author":"Tipton","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0155","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrn1100","article-title":"Targeting programmed cell death in neurodegenerative diseases","volume":"4","author":"Vila","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0160","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1471-4159.2008.05604.x","article-title":"Mitochondrial alterations in Parkinson's disease: new clues","volume":"107","author":"Vila","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0165","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.exger.2007.04.010","article-title":"Neuroinflammation in Parkinson's patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb","volume":"42","author":"Vroon","year":"2007","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0170","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11011-007-9080-3","article-title":"Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease","volume":"23","author":"Watanabe","year":"2008","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0175","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1073\/pnas.0937239100","article-title":"NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease","volume":"100","author":"Wu","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pnpbp.2011.01.017_bb0180","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10072-008-0986-2","article-title":"Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease","volume":"29","author":"Yokoyama","year":"2008","journal-title":"Neurol Sci"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611000261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611000261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T11:26:26Z","timestamp":1637234786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584611000261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0278584611000261"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.01.017","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}